Richtlijn: Erfelijke darmkanker (1.0) - Genootschap van Maag-Darm ...

More documents

Recommendations

Info

Richtlijn: Erfelijke darmkanker (1.0)Polyposis and Hereditary Nonpolyposis Colorectal Cancer). Dis Colon Rectum 2003;46:1001-12.64 - Church JChurch J. In which patients do I perform IRA, and why? Fam. Cancer 2006;5:237-40.65 - Cibula DACibula DA, Morrow CB. Determining local colorectal cancer screening utilization patterns. J Public HealthManag Pract 2003;9:315-21.66 - Claes EClaes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Philippe K, Teipar S et al. Predictive testing forhereditary non-polyposis colorectal cancer: subjective perception regarding colorectal and endometrialcancer, distress and health-related behaviour one year post-test. Genet Test 2005;9:54-65.67 - Clark SKClark SK, Phillips RKS. Desmoids in familial adenomatous polyposis. Br J Surg 1996;83:1494-504.68 - Clark SKClark SK, Smith TG, Katz DE, Reznek RH, Phillips RK. Identification and progression of a desmoidprecursor lesion in patients with familial adenomatous polyposis. Br J Surg 1998;85:970-3.69 - Clark SKClark SK, Neale KF, Landgrebe JC, Phillips RK. Desmoid tumours complicating familial adenomatouspolyposis. Br J Surg 1999;86:1185-9.70 - Clark TWClark TW. Percutaneous chemical ablation of desmoid tumors. J Vasc Interv Radiol 2003;14:629-34.71 - Clarke AClarke A. The Genetic Testing of Children. Oxford: BIOS Scientific Publishers Ltd, 1998.72 - Cobben JMCobben JM, Bröcker-Vriends AHJT, Leschot NJ. Prenatale diagnostiek naar erfelijke aanleg voor mamma/ovariumcarcinoom - een standpuntbepaling. Ned Tijdschr Geneeskd 2002;146:1461-5.73 - Codori AMCodori AM, Zawacki KL, Petersen GM, Miglioretti DL, Bacon JA, Trimbath JD et al. Genetic testing forhereditary colorectal cancer in children: long-term psychological effects. Am J Med Genet A2003;116:117-28.74 - De Cosse JJDe Cosse JJ, Bülow S, Neale K, Järvinen HK, Alm T, Hultcrantz R et al. Rectal cancer risk in patientstreated for familial adenomatous polyposis. Br J Surg 1992;79:1372-75.75 - Couture JCouture J, Mitri A, Lagace R, Smits R, Berk T, Bouchard HL et al. A germline mutation at the extreme 3'end of the APC gene results in a severe desmoid phenotype and is associated with overexpression ofbeta-catenin in the desmoid tumour. Clin Genet 2000; 57:205-12.76 - Croyle RTCroyle RT, Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer InstMonogr 1999;25:59-66.03/11/08 Erfelijke darmkanker (1.0) 91
Richtlijn: Erfelijke darmkanker (1.0)77 - Cruz -Correa MCruz-Correa M, Hylind LM, Romans K, et al. Long term treatment with sulindac in familial adenomatouspolyposis: a prospective cohort study. Gastroenterology 2002;122: 641-5.78 - Cruz-Correa MCruz-Correa M, Giardiello FM. Familial adenomatous polyposis. Gastrointest Endosc 2003;58:885-94.79 - Cummings SCummings S. The genetic testing process: how much counseling is needed? J ClinOncol.2000;18(21Suppl):60s-64s.80 - Cunningham JMCunningham JM, Kim CY, Christensen ER, Tester DJ, Parc Y, Burgart LJ et al. The frequency ofhereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am JHum Genet. 2001;69:780-90.81 - Van Dalen RVan Dalen R, Church J, McGannon E, Fay S, Burke C, Clark B. Patterns of surgery in patients belongingto Amsterdam-positive families. Dis Colon Rectum 2003;46:617-20.82 - Daly MBDaly MB, Stearman B, Masny A, Sein E, Mazzoni S. How to establish a high-risk cancer genetics clinic:limitations and successes. Curr Oncol Rep 2005;7:469-74.83 - Davey ADavey A, Rostant K, Harrop K, Goldblatt J, O'Leary P. Evaluating genetic counseling: client expectations,psychological adjustment and satisfaction with service. J Genet Couns 2005;14:197-206.84 - Dekker EDekker E, Dees J, Mathus-Vliegen L, Poley JW, Offerhaus J, Bartelsman J et al. High-resolutionendoscopy and the additional values of chromo-endoscopy in the evaluation of duodenal polyposis inFAP-patients. Abstract NVGE voorjaarsvergadering 2006.85 - Deng GDeng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA et al. BRAF mutation is frequently present insporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.Clin Cancer Res. 2004;10:191-5.86 - DevCanDevCan: Probability of Developing or Dying of Cancer Software, Version 6.1.1; Statistical Research andApplications Branch, National Cancer Institute, 2005. http://srab.cancer.gov/devcan.87 - Domingo EDomingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ et al. BRAF screening as a low-costeffective strategy for simplifying HNPCC genetic testing. J Med Genet. 2004;41:664-8.88 - Domingo EDomingo E, Niessen RC, Oliveira C, Alhopuro P, Moutinho C, Espin E et al. BRAF-V600E is not involvedin the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Oncogene2005 2;24:3995-8.89 - Dørum ADørum A, Heimdal K, Lovslett K, Kristensen G, Hansen LJ, Sandvei R et al. Prospectively detected cancerin familial breast/ovarian cancer screening. Acta Obstet Gynecol Scand 1999;78:906-11.03/11/08 Erfelijke darmkanker (1.0) 92
Page 1 and 2:
ERFELIJKE DARMKANKERLandelijke rich
Page 3 and 4:
InhoudsopgaveReferenties...........
Page 5 and 6:
Richtlijn: Erfelijke darmkanker (1.
Page 7 and 8:
Page 9 and 10:
Incidentie en risico'sLiteratuurbes
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
DiagnostiekLiteratuurbespreking:Dit
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Restrisico op mutatieRichtlijn: Erf
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44: Richtlijn: Erfelijke darmkanker (1.
Page 53: BehandelingLiteratuurbespreking:Dit
Page 71: Richtlijn: Erfelijke darmkanker (1.
Page 116 and 117: Gastroenterology 2004 Jul;127(1):9-
Page 118 and 119: Bijlagen1. Samenstelling werkgroepS
Page 142: Richtlijn: Erfelijke darmkanker (1.
show all

Richtlijn: Erfelijke darmkanker (1.0) - Genootschap van Maag-Darm ...

Create successful ePaper yourself

Delete template?

Save as template?